GLP-1 Market
LLY $1152.44 ▲ +1.3% NVO $43.19 ▲ +3.5% PFE $27.64 ▲ +0.7% VKTX $29.36 ▼ -0.5% KLRA $12.92 ▲ +1.7% GPCR $35.10 ▼ -1.1% RHHBY $54.60 ▼ -1.0%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

NB-4746

NB-4746

Company
Nura Bio
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
1 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

1 recruiting study currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 18, 2026

Find a Clinical Trial Near Me

See recruiting studies for NB-4746 and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT07369076

    A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.

    Not yet reported, Not yet reported Nura Bio 80 participants Est. completion 2028-02 12 sites Stand-alone
    Other conditions: Amyotrophic Lateral Sclerosis (ALS)
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: NB-4746, NB-4746 (Dose TBD)

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.